Jamie Samath Sells 270 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Jamie Samath also recently made the following trade(s):

• On Friday, November 29th, Jamie Samath sold 188 shares of Intuitive Surgical stock. The stock was sold at an average price of $539.00, for a total value of $101,332.00.
• On Tuesday, November 26th, Jamie Samath sold 108 shares of Intuitive Surgical stock. The shares were sold at an average price of $542.06, for a total value of $58,542.48.
• On Friday, November 8th, Jamie Samath sold 22,903 shares of Intuitive Surgical stock. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00.
• On Monday, November 11th, Jamie Samath sold 269 shares of Intuitive Surgical stock. The shares were sold at an average price of $539.89, for a total transaction of $145,230.41.

Intuitive Surgical Price Performance

ISRG stock traded up $6.63 on Wednesday, reaching $544.72. 294,601 shares of the company traded hands, compared to its average volume of 1,438,965. The firm has a fifty day simple moving average of $518.23 and a 200-day simple moving average of $476.59. The company has a market cap of $194.02 billion, a P/E ratio of 88.00, a price-to-earnings-growth ratio of 5.41 and a beta of 1.38. Intuitive Surgical, Inc. has a one year low of $314.38 and a one year high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The firm had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Hedge Funds Weigh In On Intuitive Surgical

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Ridgewood Investments LLC purchased a new stake in shares of Intuitive Surgical during the 2nd quarter valued at about $26,000. Godsey & Gibb Inc. raised its stake in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares during the last quarter. LGT Financial Advisors LLC lifted its holdings in shares of Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 54 shares during the period. MidAtlantic Capital Management Inc. purchased a new position in shares of Intuitive Surgical in the 3rd quarter worth $33,000. Finally, Capital Performance Advisors LLP purchased a new position in shares of Intuitive Surgical in the 3rd quarter worth $38,000. 83.64% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on ISRG. Piper Sandler reaffirmed an “overweight” rating and set a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Wells Fargo & Company lifted their price target on Intuitive Surgical from $549.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday. Raymond James increased their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research note on Monday, October 14th. Mizuho lifted their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Finally, Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $545.83.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.